TBC1D3 Antibodies

Santa Cruz Biotechnology features a diverse variety of TBC1D3 monoclonal antibodies for research focused on understanding TBC1D3 protein functions. TBC1D3 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TBC1D3 is a member of the TBC (Tre-2/Bub2/CDC16) domain family, which plays a significant role in regulating cellular processes such as vesicle trafficking and signal transduction. TBC1D3 influences various cellular functions, including the modulation of insulin signaling and the regulation of glucose uptake, making it a key focus for studies related to metabolic disorders. Research has shown that TBC1D3 may contribute to the development of conditions such as obesity and diabetes. Scientists studying TBC1D3 can uncover new pathways and mechanisms involved in cellular regulation and disease progression. Investigating TBC1D3 expression patterns helps reveal its distribution across different tissues and cell types. Understanding TBC1D3's role in signal transduction pathways provides valuable insights into cellular communication networks. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TBC1D3's role in human health and disease.